Hashimoto's thyroiditis overview: Difference between revisions

Jump to navigation Jump to search
Line 33: Line 33:


===Laboratory Findings===
===Laboratory Findings===
Laboratory findings consistent with the diagnosis of [[Hashimoto's thyroiditis]] usually include increased [[Thyroid-stimulating hormone|thyroid stimulating hormone]], decreased [[free T3]] and [[free T4]], and [[thyroid peroxidase|anti-thyroid peroxidase antibodies]].


===Electrocardiogram===
===Electrocardiogram===
 
The findings associated with ECG in [[Hashimoto's thyroiditis]] are [[bradycardia]] and decreased amplitude of cardiac waves.
===Chest X Ray===
===Chest X Ray===
 
The findings associated with Chest X ray in [[Hashimoto's thyroiditis]] are [[pleural effusion]] and [[cardiomegaly]].
===CT===
===CT===
Non-contrast [[Computed tomography|CT]] may be used in [[Hashimoto's thyroiditis]] to assess the [[Tracheal compression|tracheal or esophageal compression]].


===MRI===
===MRI===
There are no MRI findings associated with [[Hashimoto's thyroiditis]].


===Echocardiography or Ultrasound===
===Echocardiography or Ultrasound===
Ultrasound findings associated with [[Hashimoto's thyroiditis]] are reduced [[echogenicity]], glandular irregularities, and nodules.


===Other Imaging Findings===
===Other Imaging Findings===
24-hour [[iodine-123]] uptake is decreased in [[Hashimoto's thyroiditis]].


===Other Diagnostic Studies===
===Other Diagnostic Studies===
The histological analysis in Hashimoto's thyroiditis may show inflammatory cell infiltration and hurthle cells. [[FNA|Fine needle aspiration cytology]] helps to differentiate between the benign and malignant nodules. <ref name="pmid24434360">{{cite journal |vauthors=Caturegli P, De Remigis A, Rose NR |title=Hashimoto thyroiditis: clinical and diagnostic criteria |journal=Autoimmun Rev |volume=13 |issue=4-5 |pages=391–7 |year=2014 |pmid=24434360 |doi=10.1016/j.autrev.2014.01.007 |url=}}</ref><ref name="urlThyroiditis — NEJM">{{cite web |url=http://www.nejm.org/doi/full/10.1056/NEJMra021194 |title=Thyroiditis — NEJM |format= |work= |accessdate=}}</ref>


==Treatment==
==Treatment==

Revision as of 18:16, 20 July 2017

Hashimoto's thyroiditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hashimoto's Thyroiditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary prevention

Secondary prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hashimoto's thyroiditis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hashimoto's thyroiditis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hashimoto's thyroiditis overview

CDC on Hashimoto's thyroiditis overview

Hashimoto's thyroiditis overview in the news

Blogs on Hashimoto's thyroiditis overview

Directions to Hospitals Treating Hashimoto's thyroiditis

Risk calculators and risk factors for Hashimoto's thyroiditis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]

Overview

Hashimoto's thyroiditis or chronic lymphocytic thyroiditis is an autoimmune disease where the body's own antibodies attack the cells of the thyroid.

Historical Perspective

Hashimoto's thyroiditis was first described by Hashimoto Hakaru in 1912. He named it struma lymphomatosa which was renamed as Hashimoto's thyroiditis in 1931.

Classification

Pathophysiology

Hashimoto's thyroiditis (HT) is characterized by Lymphocytic infiltration of the thyroid gland and production of antibodies that recognize thyroid-specific antigens.The pathogenesis is not yet completely understood. It is currently thought that the disease is caused by abnormalities in cellular and humoral immunity which results in a localized cell-mediated immune response directed toward the thyroid parenchymal cells. This results in the decreased production of thyroid hormones.

Causes

Differentiating Hashimoto's Thyroiditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Laboratory findings consistent with the diagnosis of Hashimoto's thyroiditis usually include increased thyroid stimulating hormone, decreased free T3 and free T4, and anti-thyroid peroxidase antibodies.

Electrocardiogram

The findings associated with ECG in Hashimoto's thyroiditis are bradycardia and decreased amplitude of cardiac waves.

Chest X Ray

The findings associated with Chest X ray in Hashimoto's thyroiditis are pleural effusion and cardiomegaly.

CT

Non-contrast CT may be used in Hashimoto's thyroiditis to assess the tracheal or esophageal compression.

MRI

There are no MRI findings associated with Hashimoto's thyroiditis.

Echocardiography or Ultrasound

Ultrasound findings associated with Hashimoto's thyroiditis are reduced echogenicity, glandular irregularities, and nodules.

Other Imaging Findings

24-hour iodine-123 uptake is decreased in Hashimoto's thyroiditis.

Other Diagnostic Studies

The histological analysis in Hashimoto's thyroiditis may show inflammatory cell infiltration and hurthle cells. Fine needle aspiration cytology helps to differentiate between the benign and malignant nodules. [1][2]

Treatment

Medical Therapy

The mainstay of therapy for Hashimoto's thyroiditis is synthetic levothyroxine. Corticosteroids and selenium can also be used in certain cases.

Surgery

Thyroidectomy is usually performed when the enlarged thyroid produces cervical compression symptoms and there is a high suspicion for malignancy.

Primary Prevention

There are no primary preventive measures available for Hashimoto's thyroiditis.

Secondary Prevention

There are no secondary preventive measures available for Hashimoto's thyroiditis.

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

References

  1. Caturegli P, De Remigis A, Rose NR (2014). "Hashimoto thyroiditis: clinical and diagnostic criteria". Autoimmun Rev. 13 (4–5): 391–7. doi:10.1016/j.autrev.2014.01.007. PMID 24434360.
  2. "Thyroiditis — NEJM".

Template:WH Template:WS